Lawyer finder

Andrew Glaze

Director
Andrew Glaze

A director in the Corporate group's Mergers & Acquisitions team, providing advice on a wide range of corporate finance transactions. My particular focus is on large M&A transactions for major corporate clients.

Tel: +44 (0)121 629 1868
Email: andrew_glaze@wragge.com

Services: Corporate

Best brains in...

I have particular expertise in the area of M&A transactions governed by the takeover code, as well as in equity markets regulation generally. I have acted on several public takeovers implemented by means of complex schemes of arrangement. In addition, I have extensive experience of high value cross-border M&A transactions for major corporate clients and property developers.

Highlight of your career so far?

Certainly the deal that was the most fun to do involved the takeover of a household name high street retailer. I led and completed the structuring of the transaction, which involved some complex analysis of difficult company law issues.

There was a great chemistry among the members of the team and the clients. The whole deal was complicated at the end of the transaction by an interloper that tried to scupper the deal at the last minute!

Most challenging job you've ever done?

While many jobs are challenging for different reasons, the most technically complex piece of work I advised on involved an acquisition of an AIM-listed client by means of a scheme of arrangement. The consideration mix that was made available to the target's shareholders was extremely complicated. It necessitated a detailed share capital re-organisation in a tight timescale.

In addition, the offer was the first in the country to be governed by new takeover rules, including announcing plans for employees and the target company. On top of all this, the timing of the transaction meant the announcement of the offer and the posting of the relevant scheme documents had to be produced over successive bank holiday weekends.

What about outside the UK?

A lot of my work involves an international element, particularly as many of my clients in the M&A arena are based in the US. International deals require careful handling – it's crucial to be aware of the balance between the law and the practicalities of how things are likely to be dealt with in the particular territory. My best example involved a large multi-jurisdictional acquisition for a large, international organisation. With several jurisdictions and different corporate issues in each of these, it required a complete handle on the issues in several different time zones.

What's your definition of going the extra mile... And when have you done it?

I think that would be when I was acting for the selling shareholders in connection with the sale of property development client Rosemound Developments to Macquarie Goodman Group.

This was a large deal for great clients, which overran the target completion date, meaning that I was late starting my holiday which I was taking in order to get married. Fortunately, we got the deal done just in time for me to make it to the church on time...!

Best example of a creative legal solution?

The key to providing creative legal solutions is to try and simplify and demystify complex legal issues so that clients can make properly informed, commercial decisions. It's really important to tell clients in plain English what you would do in any particular situation, and why, rather than just spelling out the law and leaving the decision to them.

What's your single greatest contribution to Wragge & Co's corporate responsibility?

I have completed the last two New York Marathons, raising several thousands of pounds for the charity SENSE - the UK's largest deafblind charity.

What's been written or said about you that you're most proud of?

I was once described as a "fabulous M&A lawyer who clients both like and respect". I am quite proud of that!

Alerts

15.06.10

Company law and corporate governance

Following a review of corporate governance by the Financial Reporting Council a new corporate governance code, 'the UK Corporate Governance Code' (previously the Combined Code), has been published.

03.03.10

Premium and Standard Listings: the two-tier UK Listing Regime

Companies looking at a stock market quotation now have a wider choice of listing category to consider as the Official List, the London Stock Exchange's main market for listed securities, now has two tiers: a premium and a standard listing.

 

Press releases

20.11.09

Wragge & Co's Corporate and Property teams advise Conygar on £44.6 million acquisition

Wragge & Co LLP's Property and Corporate teams have advised long-standing client Conygar Investment Company plc on its £44.6 million acquisition of six property holding companies from Lamont Property (Jersey) Limited.

15.10.09

Wragge & Co Public Companies team advises Conygar on hostile public takeover

Wragge & Co LLP Equity Markets team has advised AIM listed property company, The Conygar Investment Company Plc, on its successful hostile reverse takeover of London and Channel Islands listed company, the Advantage Property Income Trust Limited (TAP).

20.08.08

Wragge & Co Corporate group advises E.ON UK plc on street lighting deal

Wragge & Co LLP Corporate group has advised E.ON UK plc on acquiring a 60% share of Lighting for Staffordshire Holdings Limited from ABB Holdings Limited and ABB Limited. The transaction has enabled E.ON to expand its activities in the street lighting

12.08.08

Wragge & Co advises on cross-border M&A deal

Wragge & Co LLP Corporate group has advised Spectris plc subsidiary company HBM on its acquisition of US-based nCode International. The £17.5 million deal will enable HBM to strengthen its presence in North America.

06.08.08

Wragge & Co advises Hill & Smith on €54 million deal double

Wragge & Co LLP Corporate group has advised Hill & Smith Holdings PLC on the €23.7 million acquisition of a minority holding in Zinkinvent GmbH. A simultaneous second transaction involved the disposal of Zinkinvent's German and Benelux operations.

 

Published articles

11.04.11

Wragge & Co advises on £91 million life sciences deal

Wragge & Co's corporate experts have advised Astex Therapeutics on its proposed £91 million cross-border acquisition by NASDAQ-listed SuperGen Inc.

 

Search for lawyer